Rigel Pharmaceuticals Inc (RIGL) — Tangible Net Worth Ratio
Rigel Pharmaceuticals Inc (RIGL) has a Tangible Net Worth Ratio of 94.0% as of March 2026. This metric is calculated by deducting intangible assets ($24.16 Million) from net assets ($399.90 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See how liquid is Rigel Pharmaceuticals Inc's working capital to evaluate short-term liquidity relative to the company's equity base.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Rigel Pharmaceuticals Inc Tangible Net Worth Ratio (1999–2025)
This chart shows how Rigel Pharmaceuticals Inc's Tangible Net Worth Ratio has changed across 25 annual periods from 1999 to 2025. As of March 2026, the ratio stands at 94.0%, reflecting net assets of $399.90 Million with intangible assets of $24.16 Million USD. See RIGL defensive asset coverage days to measure how many days the company can operate on defensive assets alone.
Annual Tangible Net Worth Ratio for Rigel Pharmaceuticals Inc (1999–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for Rigel Pharmaceuticals Inc from 1999 to 2025, covering 25 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see RIGL company net worth.
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 93.7% | $391.48 Million | $24.75 Million | $513.59 Million | ▲ +817.9 pp |
| 2024 | -724.2% | $3.29 Million | $27.10 Million | $163.98 Million | ▼ -824.2 pp |
| 2021 | 100.0% | $30.37 Million | $0.00 | $167.33 Million | ▲ +0.0 pp |
| 2020 | 100.0% | $34.03 Million | $0.00 | $110.38 Million | ▲ +0.0 pp |
| 2019 | 100.0% | $53.81 Million | $0.00 | $147.57 Million | ▲ +0.0 pp |
| 2018 | 100.0% | $109.88 Million | $0.00 | $139.11 Million | ▲ +0.0 pp |
| 2017 | 100.0% | $100.65 Million | $0.00 | $119.11 Million | ▲ +0.0 pp |
| 2016 | 100.0% | $55.03 Million | $0.00 | $78.13 Million | ▲ +0.0 pp |
| 2015 | 100.0% | $91.38 Million | $0.00 | $131.75 Million | ▲ +0.0 pp |
| 2014 | 100.0% | $128.25 Million | $0.00 | $154.13 Million | ▲ +0.0 pp |
| 2013 | 100.0% | $208.25 Million | $0.00 | $226.06 Million | ▲ +0.0 pp |
| 2012 | 100.0% | $289.10 Million | $0.00 | $310.04 Million | ▲ +0.0 pp |
| 2011 | 100.0% | $236.15 Million | $0.00 | $257.11 Million | ▲ +0.0 pp |
| 2010 | 100.0% | $166.13 Million | $0.00 | $186.69 Million | ▲ +0.0 pp |
| 2009 | 100.0% | $109.87 Million | $0.00 | $140.74 Million | ▲ +0.0 pp |
| 2008 | 100.0% | $104.17 Million | $0.00 | $143.86 Million | ▲ +0.0 pp |
| 2007 | 100.0% | $82.18 Million | $0.00 | $115.79 Million | ▲ +0.0 pp |
| 2006 | 100.0% | $87.23 Million | $0.00 | $113.24 Million | ▲ +0.0 pp |
| 2005 | 100.0% | $108.59 Million | $0.00 | $147.67 Million | ▲ +0.0 pp |
| 2004 | 100.0% | $52.30 Million | $0.00 | $78.82 Million | ▲ +0.0 pp |
| 2003 | 100.0% | $39.97 Million | $0.00 | $55.52 Million | ▲ +0.0 pp |
| 2002 | 100.0% | $25.44 Million | $0.00 | $44.34 Million | ▲ +0.0 pp |
| 2001 | 100.0% | $28.94 Million | $0.00 | $46.45 Million | ▲ +0.0 pp |
| 2000 | 100.0% | $49.01 Million | $0.00 | $64.26 Million | ▲ +0.0 pp |
| 1999 | 100.0% | $756.00K | $0.00 | $17.17 Million | — |